Literature DB >> 17136822

Postprandial hyperglycemia is a possible contributor to paroxysmal atrial fibrillation: a case report.

Toru Kato1, Shiro Ishida, Toshifumi Morooka, Teruo Inoue, Koichi Node.   

Abstract

Atrial fibrillation, a major risk factor for stroke, is believed to occur first as paroxysmal episodes, gradually becoming more persistent, and finally progressing to chronic atrial fibrillation. Treatment of paroxysmal atrial fibrillation is an important target to prevent chronic atrial fibrillation. We describe a very unique case with postprandial hyperglycemia and obesity associated with drug-refractory paroxysmal atrial fibrillation. A 73-year-old Japanese woman with postprandial hyperglycemia suffered from drug-refractory paroxysmal atrial fibrillation. A 1600 kcal/day diet and walking three times/day for more than 30 min eliminated paroxysmal atrial fibrillation after 6 months. Diet and exercise should be considered as the initial therapy in patients with paroxysmal atrial fibrillation who also have postprandial hyperglycemia. This case suggests that postprandial hyperglycemia and insulin resistance might be one of the possible underlying mechanisms of paroxysmal atrial fibrillation.

Entities:  

Mesh:

Year:  2006        PMID: 17136822

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  3 in total

1.  Association of stress hyperglycemia and atrial fibrillation in myocardial infarction.

Authors:  Goran P Koracevic; Sladjana Petrovic; Miodrag Damjanovic; Teodora Stanojlovic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  The effects of diffusion and perfusion MRI mismatch on the admission blood glucose and blood pressure values measured in the first 12 hours of acute stroke.

Authors:  Selen Gür-Özmen; Özlem Güngör-Tunçer; Yakup Krespi
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects.

Authors:  Odd Erik Johansen; Ellen Brustad; Steve Enger; Arnljot Tveit
Journal:  Cardiovasc Diabetol       Date:  2008-09-28       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.